Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis

Low socioeconomic status at the neighborhood level may increase the risk of POMS while high parental education may be protective against POMS. Although we did not find associations of other evaluated prenatal or postnatal adversities with POMS, future research should explore such associations further by assessing a broader range of stressful childhood experiences.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2024-08-15
DOI
https://doi.org/10.1212/nxi.0000000000200282
Citations
4
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis

Jan-Mendelt Tillema, Anne E. Berens, Manu S. Goyal, Mark Gorman et al.
4 citations
Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research Studies
1.70
article

Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis

Jan-Mendelt Tillema, Anne E. Berens, Manu S. Goyal, Mark Gorman, Lauren Krupp, Amy Tara Waldman, Ilana Kahn, Leslie A. Benson, Leigh Charvet, Emmanuelle L. Waubant, Jayne Ness, Yolanda Wheeler, John W. Rose, Jennifer Rubin, Moses Rodriguez, Teri Schreiner, Tanuja Chitnis, Meghan Candee, Susana Camposano, Jennifer S. Graves, Gregory Scott Aaen, Soe Mar, Mary R. Rensel, Timothy E. Lotze, Bianca Weinstock‐Guttman, Lisa F. Barcellos, Anita Belman, Theron Charles Casper, Sarah K. G. Jensen, Michael Waltz
article en
4 citations

Abstract

Low socioeconomic status at the neighborhood level may increase the risk of POMS while high parental education may be protective against POMS. Although we did not find associations of other evaluated prenatal or postnatal adversities with POMS, future research should explore such associations further by assessing a broader range of stressful childhood experiences.

Neurology Neuroimmunology & NeuroinflammationVol. 11(5)
Multiple Sclerosis Society (GB)
Bristol-Myers Squibb, Biogen, Patient-Centered Outcomes Research Institute, Alexion Pharmaceuticals, Celgene, European Committee for Treatment and Research in Multiple Sclerosis, National Society of Genetic Counselors, Ionis Pharmaceuticals, Race to Erase MS, Australian Government, Multiple Sclerosis Society, Eisai, Genentech, EMD Serono
Openalex Percentile: Top 16%
Multiple Sclerosis Research Studies
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.